Global MicroRNA Market Accelerates as Oncology and Diagnostics Advance
The global microRNA market , valued at USD 2.27 billion in 2024 and projected to grow at a CAGR of 11.50% through 2034, is significantly influenced by the research capabilities and innovation ecosystems of leading countries including the United States, China, Germany, and the United Kingdom. These nations not only contribute substantially to global research funding and patent applications but also serve as centers of technological advancement and regulatory development that shape market trends worldwide. The United States maintains a dominant position through its robust biotechnology sector, advanced research infrastructure, and concentration of key manufacturing facilities in biotechnology hubs such as California, Massachusetts, and Maryland. National policy impact is particularly evident through FDA regulations governing diagnostic tests and NIH funding programs that support genomic research initiatives, which drive innovation in microRNA assay development and clinical validati...